LCN2 and acute kidney injury: A diagnostic superiority in terms of sensitivity and specificity of this test was also revealed when compared to other renal biomarkers, such as urine or plasma NGAL, with a better prediction of moderate to severe AKI (KDIGO stage 2 to 3) in more than one thousand critically ill patients [7].